Haemonetics (HAE) Stock Price, Quote, News & History | Benzinga

Haemonetics Corp (HAE) Stock Price, Quote, News & History

HAENYSE

Trade with Public

Trade with Public

$108.80

0.580.54%

At close: Aug 21, 5:00 PM EST

$108.80

N/A

After Hours: Aug 21, 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$109.24

Close

$108.80

Volume / Avg.

582.12K / 891.54K

Day Range

$107.00 - $109.57

52 Wk Range

47.32 - 109.56

Market Cap

$4.95B

P/E Ratio

52.28

Dividend Yield

-

Exchange

NYSE

RSI

85

Short Interest

7.51%

Days to Cover

4.57

Recent Haemonetics Corp News

Ross Stores To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed outlook on top names. Baird raised PSN target, BTIG cut WMT target, HSBC raised TX target, Rothschild upgraded EFX, HC Wainwright lowered COCH target, BTIG cut MDXH target, Baird raised ROST target.

Avi Kapoor

Haemonetics Shares Hit New 52-Week High: What's Happening?

Shares of Haemonetics Corp (NYSE: HAE) are trading higher Tuesday afternoon following news of a significant commercial agreement.

Henry Khederian

Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday

US stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other big stocks gain, including Duolingo, Intuit, and Newsmax.

Avi Kapoor

This Texas Instruments Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday

Analysts upgraded HAE, VIK, and TXN, and raised price targets. Check out other analysts' views on these stocks. Consider buying TXN stock.

Avi Kapoor

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

328.15M

Investing Cash Flow (TTM)

-168.78M

Financing Cash Flow (TTM)

-227.55M

Free Cash Flow (TTM)

291.22M

Capital Expenditure (TTM)

-36.93M

Net Change in Cash (TTM)

-68.18M

Analyst Trends and Forecast

2

2

May

3

Jun

1

Jul

4

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.90B

PE Ratio (TTM)

52.28

PE Ratio (FWD)

20.58

PEG Ratio (TTM)

1.71

PS Ratio (TTM)

3.74

PB Ratio (TTM)

5.88

Earnings Yield % (TTM)

1.91%

Earnings Yield % (FWD)

4.86%

EV / EBITDA (TTM)

21.73

Price / EBITDA (TTM)

18.69

Price / Free Cash Flow (TTM)

17.35

Book Value / Share

$18.40

Company Debt

Total Debt

$1.17B

LT Debt

$1.17B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$306.25M

Total Cash

$223.38M

Debt to Equity

1.40

Issuance of Debt (TTM)

-$6.25M

Repayment of Debt (TTM)

-$356.25M

Key Statistics

Open

$109.24

Close

$108.80

Volume / Avg.

582.12K / 891.54K

Day Range

$107.00 - $109.57

52 Wk Range

47.32 - 109.56

Market Cap

$4.95B

P/E Ratio

52.28

Dividend Yield

-

Exchange

NYSE

RSI

85

Short Interest

7.51%

Days to Cover

4.57

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company op...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Haemonetics (HAE) stock?

A

You can purchase shares of Haemonetics (NYSE:HAE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Haemonetics (HAE) competitors?

A

Other companies in Haemonetics’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).

Q

What is the forecast, or price target, for Haemonetics (HAE) stock?

A

Haemonetics has a consensus price target of $96.64.

Q

What is the current price for Haemonetics (HAE)?

A

The stock price for Haemonetics (NYSE: HAE) is $108.8 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Haemonetics (HAE) pay a dividend?

A

There are no upcoming dividends for Haemonetics.

Q

When is Haemonetics (NYSE:HAE) reporting earnings?

A

Haemonetics does not have any upcoming earnings scheduled.

Q

Is Haemonetics (HAE) going to split?

A

There is no upcoming split for Haemonetics.

Q

What sector and industry does Haemonetics (HAE) operate in?

A

Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.